Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir

ClinicalTrials.gov ID: NCT02103699

Public ClinicalTrials.gov record NCT02103699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Study to Examine Patient Characteristics, Health Care Management, and Effectiveness Among HCV Patients Treated With Simeprevir at Various Practice Settings

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effectiveness of a simeprevir-containing hepatitis C virus (HCV) treatment regimen as measured by sustained virologic response (SVR).

Study identification

NCT ID
NCT02103699
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Janssen Scientific Affairs, LLC
Industry
Enrollment
315 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Oct 31, 2015
Completion
Dec 31, 2015
Last update posted
Feb 21, 2016

2014 – 2016

United States locations

U.S. sites
32
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Not listed Phoenix Arizona
Not listed Bakersfield California
Not listed Beverly Hills California
Not listed Los Angeles California
Not listed Daytona Beach Florida
Not listed DeLand Florida
Not listed Miami Florida
Not listed Tampa Florida
Not listed West Palm Beach Florida
Not listed Crestview Hills Kentucky
Not listed Baltimore Maryland
Not listed Springfield Massachusetts
Not listed Newark New Jersey
Not listed Vineland New Jersey
Not listed Brooklyn New York
Not listed Flushing New York
Not listed New York New York
Not listed Durham North Carolina
Not listed Fayetteville North Carolina
Not listed Rocky Mount North Carolina
Not listed Statesville North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Doylestown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Nashville Tennessee
Not listed Austin Texas
Not listed Dallas Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed Murray Utah
Not listed Norfolk Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02103699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02103699 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →